Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
10 May 2014 - eP170
Vancomycin MIC creep: a fact or an artifact?
Maria Souli, Souli, M.(1)*; Giamarellou On behalf of The Hellenic Study Group on Staphylococcal Infections, H.(2);
10 May 2014 - eP171
Current analysis of oritavancin potency when tested against vancomycin-resistant/susceptible enterococcal clinical isolates recovered from European medical centres (2009-2013)
Rodrigo E. Mendes, Mendes, R.E.(1)*; Farrell, D.J.(1); Streit, J.M.(1); Jones, R.N.(1);
10 May 2014 - eP172
Activity of oritavancin and comparator agents against multidrug-resistant staphylococcal and streptococcal isolates responsible for documented infections in European hospitals (2011-2013)
Rodrigo E. Mendes, Mendes, R.E.(1)*; Farrell, D.J.(1); Flamm, R.K.(1); Sader, H.S.(1); Jones, R.N.(1);
10 May 2014 - eP173
Longitudinal study of the activity of oritavancin (ORI) against Staphylococcus aureus (SA) from Europe (EU) between 2011 and 2013
Francis Arhin, Sahm, D.F.(1)*; Draghi, D.C.(1); Moeck, G.(2); Arhin, F.F.(2);
10 May 2014 - eP174
Oritavancin does not antagonise the activity of common antibacterial agents for Gram-positive and Gram-negative infections
Adam Belley, Belley, A.(1)*; Arhin, F.F.(1); Moeck, G.(1);
10 May 2014 - eP175
Susceptibility of clinical Staphylococcus and Enterococcus isolates to glycopeptides, linezolid and daptomycin in oncohaematological patients in northwestern Greece, during a two-year period
Stamatina Levidiotou, Priavali, E.(1); Gartzonika, C.(1); Karagianni, P.(1); Nita, E.(1); Gesouli, E.(1); Levidiotou, S.(1)*;
10 May 2014 - eP176
Mutant prevention concentration (MPC) values of tedizolid (TDZ) against clinical strains of methicillin-resistant Staphylococcus aureus (MRSA) shows a low propensity for resistance selection
Joseph M. Blondeau, Alsaeed, A.(1); Shebelski, S.(1); Blondeau, J.(1)*;
10 May 2014 - eP177
Beta-lactam combinations with daptomycin provide synergy against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci
Jordan Smith, Smith, J.(1)*; Barber, K.(1); Rybak, M.(1);
10 May 2014 - eP178
Pharmacodynamic profile of commonly utilised parenteral therapies against methicillin-susceptible/resistant Staphylococcus aureus from US hospitals
David Nicolau, Housman, S.T.(1); Sutherland, C.A.(1); Nicolau, D.P.(1)*;
10 May 2014 - eP179
In vitro activity of ceftaroline against Staphylococcus aureus using concentrations achieved in humans determined by time-kill methodology
Michael Kresken, Kresken, M.(1)*; Körber-Irrgang, B.(1);
10 May 2014 - eP180
Allosteric site missense mutations in PBP2a affecting ceftaroline susceptibility detected in epidemic HA-MRSA clonotypes ST228 (south German) and ST247 (Iberian) in western Switzerland
Adriana Renzoni, Kelley, W.L.(1); Jousselin, A.(1); Barras, C.(1); Lelong, E.(1); Renzoni, A.(1)*;
10 May 2014 - eP181
Comparative in vitro efficacy of ceftaroline and other anti-staphylococcal antibiotics against a nationwide collection of nosocomial Staphylococcus aureus clinical isolates from Greece
Maria Souli, Souli, M.(1)*; Giamarellou On behalf of The Hellenic Study Group on Staphylococcal Infections, H.(2);
10 May 2014 - eP182
In vitro antimicrobial activity of ceftaroline against S. aureus strains isolated in Spain
Alberto Tenorio-Abreu, Tenorio-Abreu, A.(1)*; Gil Tomás, J.(2); Rodríguez-Molins, E.(3); Ortiz de Lejarazu Leonardo, R.(4); Borrás Máñez, M.(2); Colomina Rodríguez, J.(2); Saavedra Martín, J.M.(5); Márquez Sanabria, A.(5); Domínguez Castaño, A.(5); De La Iglesia Salgado, M.(5);
10 May 2014 - eP183
In vitro activity of ceftaroline against EP15T mecC-positive methicillin-resistant Staphylococcus aureus from humans and livestock
Petra Camernik, Cercenado, E.(1)*; García-Garrote, F.(2); Marín, M.(1); Vindel, A.(3); Méndez, A.(4); Bouza, E.(1);
10 May 2014 - eP184
The use of natural alkaloids and flavonoids in combination with antibiotics to prevent and control Staphylococcus aureus biofilms
Ana Cristina Abreu, Abreu, A.C.(1)*; Gomes, I.(1); Malheiro, J.(1); Simões, M.(1);
10 May 2014 - eP185
Activity of the peptide deformylase inhibitor GSK1322322 against intracellular forms of susceptible and resistant S. aureus: comparison with azithromycin, clindamycin, linezolid, vancomycin, daptomycin, and moxifloxacin
Paul M. Tulkens, Peyrusson, F.(1); Tulkens, P.M.(1)*; Van Bambeke, F.(1);
10 May 2014 - eP186
In vitro activities of telavancin, vancomycin and linezolid against Gram-positive organisms isolated from cancer patients
Kenneth V.I. Rolston, Rolston, K.(1)*; Wang, W.(2); Nesher, L.(1); Coyle, E.(2); Shelburne, S.(1); Prince, R.(2);
10 May 2014 - eP187
Antimicrobial activity of ceftobiprole tested against staphylococci and streptococci from European countries and Israel (2013)
Robert Flamm, Flamm, R.K.(1)*; Farrell, D.J.(1); Streit, J.M.(1); Sader, H.S.(1); Jones, R.N.(1);
10 May 2014 - eP188
Ceftobiprole activity tested against bacterial isolates from hospitalised patients with pneumonia in European hospitals and Israel (2013)
Robert Flamm, Flamm, R.K.(1)*; Farrell, D.J.(1); Streit, J.M.(1); Sader, H.S.(1); Jones, R.N.(1);
10 May 2014 - eP189
In vitro and in vivo susceptibility of Streptococcus pyogenes to trimethoprim-sulphamethoxazole in northern Australia
Asha Clare Bowen, Bowen, A.C.(1)*; Tong, S.Y.C.(2); McDonald, M.I.(3); Carapetis, J.R.(4);
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.